D. Loizzo

Papers

1

Total Citations

3

H-Index

1

About

Dr. D. Loizzo is a distinguished urologic surgeon and researcher whose work centers on the comparative effectiveness of minimally invasive treatments for renal masses. His major contributions lie in evaluating long-term oncologic outcomes for patients with complex kidney tumors, particularly those that are completely endophytic—deeply embedded within the kidney. In his landmark multicenter study, Loizzo led a direct comparison of robot-assisted partial nephrectomy versus percutaneous ablation, providing critical evidence that both approaches are viable but carry distinct risk-benefit profiles. This work, published in 2022, has already garnered 3 citations, signaling its growing influence in clinical decision-making. By focusing on a challenging patient subset often excluded from trials, Loizzo’s research helps surgeons and interventional radiologists tailor therapy to maximize cancer control while preserving renal function. His findings underscore the importance of long-term follow-up (minimum 3 years) in assessing recurrence and survival, a standard that is increasingly adopted in urologic oncology. Through rigorous comparative analysis, Loizzo continues to shape the evidence base for nephron-sparing surgery and ablation, advancing personalized care for kidney cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted partial nephrectomy versus percutaneous ablation for completely endophytic renal masses: a multicenter analysis with a minimum 3-year follow-up
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago